Spondyloarthropathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
Here are some labeled data that shows not only the prevalence of spondyloarthropathies but also the prevalence of HLA-B27 and its subtype. | Here are some labeled data that shows not only the prevalence of spondyloarthropathies but also the prevalence of HLA-B27 and its subtype. | ||
{| style="border: 3px; font-size; 190%; margin: 1px; width: 800px" align="center" | |||
! colspan="6" style="background: #ff8c00; width: 800px:" | {{fontcolor|#FFF|Prevalence of AS and related spondyloarthropathies throughout different populations}} | |||
|- | |||
! rowspan="2" style="background: #1e90ff; width: 200px;" | {{fontcolor|#FFF|populations}} | |||
! rowspan="2" style="background: #1e90ff; width: 200px;" | {{fontcolor|#FFF|B27 frequency}} | |||
! colspan="2" style="background: #1e90ff; width: 200px;" | {{fontcolor|#FFF|Prevalence of AS}} | |||
! colspan="2" style="background: #1e90ff; width: 200px;" | {{fontcolor|#FFF|Prevalence of SpA | |||
(including AS)}} | |||
|- | |||
! style="background: #1e90ff; width: 200px;" | {{fontcolor|#FFF|General population}} | |||
! style="background: #1e90ff; width: 200px;" | {{fontcolor|#FFF|B27+ part of population}} | |||
! style="background: #1e90ff; width: 200px;" | {{fontcolor|#FFF|General population}} | |||
! style="background: #1e90ff; width: 200px;" | {{fontcolor|#FFF|B27+ part of population}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |Eskimos (Alaska) | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |40% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |0.4% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |2.5% | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |Skimos (Alaska & Siberia) & Chukcki | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |25-40% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |1.6% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |2-3.4% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |4.2% | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |Samis (Lapland) | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |24% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |1.8% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |6.8% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |Northern Norway | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |10-16% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |1.4% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |Mordovia | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |16% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |0.5% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |Europe (Western) | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |8% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |0.2% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |2% | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
| style="padding: 5px 5px; background: #DCDCDC; " align="center" |.. | |||
|} | |||
.. | |||
Revision as of 08:15, 29 August 2018
epidemiology and demographics
Spondyloarthropathy (SpA) is a world wide disease but it has been seen mostly throughout Europe, Asia, North Africa, and North America, which are the places for presence of HLA-B27. SpA and HLA-B27 is somehow absent among genetically unmixed native populations of South Africa and Australia.
Here are some labeled data that shows not only the prevalence of spondyloarthropathies but also the prevalence of HLA-B27 and its subtype.
| Prevalence of AS and related spondyloarthropathies throughout different populations | |||||
|---|---|---|---|---|---|
| populations | B27 frequency | Prevalence of AS | Prevalence of SpA
(including AS) | ||
| General population | B27+ part of population | General population | B27+ part of population | ||
| Eskimos (Alaska) | 40% | 0.4% | .. | 2.5% | |
| Skimos (Alaska & Siberia) & Chukcki | 25-40% | .. | 1.6% | 2-3.4% | 4.2% |
| Samis (Lapland) | 24% | 1.8% | 6.8% | .. | .. |
| Northern Norway | 10-16% | 1.4% | .. | .. | .. |
| Mordovia | 16% | 0.5% | .. | .. | .. |
| Europe (Western) | 8% | 0.2% | 2% | .. | .. |
..